











Our Purpose
Panacea Biotec believes in nurturing and nourishing Life on the way to better health

Panacea Biotec, in partnership with the Indian Council of Medical Research (ICMR), initiated Phase III clinical trials for DengiALL®, a tetravalent dengue vaccine.
Honored to host Wharton professors at Panacea Biotec! We discussed our journey in global health, affordable innovation, and India's role. Grateful for the inspiring exchange.
Dr. Rajesh Jain describing Panacea Biotec 2.0 strategy and what the future holds at Panacea Biotec.